首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Rapid Structure Determination of Microcrystalline Molecular Compounds Using Electron Diffraction
【2h】

Rapid Structure Determination of Microcrystalline Molecular Compounds Using Electron Diffraction

机译:电子衍射快速测定微晶分子化合物的结构

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chemists of all fields currently publish about 50 000 crystal structures per year, the vast majority of which are X‐ray structures. We determined two molecular structures by employing electron rather than X‐ray diffraction. For this purpose, an EIGER hybrid pixel detector was fitted to a transmission electron microscope, yielding an electron diffractometer. The structure of a new methylene blue derivative was determined at 0.9 Å resolution from a crystal smaller than 1×2 μm2. Several thousand active pharmaceutical ingredients (APIs) are only available as submicrocrystalline powders. To illustrate the potential of electron crystallography for the pharmaceutical industry, we also determined the structure of an API from its pill. We demonstrate that electron crystallography complements X‐ray crystallography and is the technique of choice for all unsolved cases in which submicrometer‐sized crystals were the limiting factor.
机译:目前,所有领域的化学家每年都会发布约50 000个晶体结构,其中绝大多数是X射线结构。我们通过电子而不是X射线衍射确定了两个分子结构。为了这个目的,将EIGER混合像素检测器安装到透射电子显微镜上,得到电子衍射仪。从小于1×2μm 2 的晶体中以0.9Å的分辨率确定了新的亚甲基蓝衍生物的结构。数千种活性药物成分(API)仅以亚微晶粉形式提供。为了说明电子晶体学在制药行业的潜力,我们还从药丸中确定了API的结构。我们证明了电子晶体学是X射线晶体学的补充,并且是亚微米级晶体成为限制因素的所有未解决情况的首选技术。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号